Medicure Inc. (TSXV: MPH)
Canada
· Delayed Price · Currency is CAD
0.880
0.00 (0.00%)
Nov 19, 2024, 9:43 AM EST
Medicure Revenue
Medicure had revenue of 5.17M CAD in the quarter ending June 30, 2024, a decrease of -13.82%. This brings the company's revenue in the last twelve months to 20.93M, down -9.87% year-over-year. In the year 2023, Medicure had annual revenue of 21.69M, down -5.94%.
Revenue (ttm)
20.93M
Revenue Growth
-9.87%
P/S Ratio
0.44
Revenue / Employee
550.84K
Employees
38
Market Cap
9.18M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 21.69M | -1.37M | -5.94% |
Dec 31, 2022 | 23.07M | 1.32M | 6.08% |
Dec 31, 2021 | 21.74M | 10.13M | 87.29% |
Dec 31, 2020 | 11.61M | -8.56M | -42.45% |
Dec 31, 2019 | 20.17M | -8.94M | -30.70% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Bausch + Lomb Corporation | 6.33B |
Bausch Health Companies Inc. | 12.80B |
Curaleaf Holdings, Inc. | 1.83B |
dentalcorp Holdings Ltd. | 1.51B |
Tilray Brands, Inc. | 1.10B |
Sienna Senior Living Inc. | 867.55M |
WELL Health Technologies Corp. | 957.69M |
Cronos Group Inc. | 150.26M |
Medicure News
- 2 days ago - Medicure to Present Financial Results on November 26, 2024 Call at 8:30 AM ET for Quarter Ended September 30, 2024 and Announces Resignation of Board Member - Accesswire
- 27 days ago - Medicure Announces Positive Settlement of Product Development and Supply Contracts - Accesswire
- 3 months ago - Medicure Announces Closing of Asset Purchase Agreement with Canam Bioresearch for Acquisition of Intellectual Property - Accesswire
- 3 months ago - Medicure Reports Financial Results for Quarter Ended June 30, 2024 - Accesswire
- 5 months ago - Medicure Announces Signing of Asset Purchase Agreement with CanAm Bioresearch Inc. for Acquisition of Intellectual Property - Accesswire
- 7 months ago - Medicure Receives US FDA Fast Track Designation for MC-1 for PNPO Deficiency - Accesswire
- 8 months ago - Medicure Reports Financial Results for Quarter and Year Ended December 31, 2023 - Accesswire
- 8 months ago - Medicure To Present Financial Results on April 9, 2024 Call at 8:30 AM ET for Quarter and Year Ended December 31, 2023 - Accesswire